These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16127035)
1. 2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials. Nduati E; Hunt S; Kamau EM; Nzila A Antimicrob Agents Chemother; 2005 Sep; 49(9):3652-7. PubMed ID: 16127035 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum. Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of de novo folate enzymes in Plasmodium falciparum. Nzila A Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs. Winstanley PA; Mberu EK; Szwandt IS; Breckenridge AM; Watkins WM Antimicrob Agents Chemother; 1995 Apr; 39(4):948-52. PubMed ID: 7786001 [TBL] [Abstract][Full Text] [Related]
5. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum. Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI Biochem Pharmacol; 1997 Apr; 53(7):943-50. PubMed ID: 9174107 [TBL] [Abstract][Full Text] [Related]
6. Plasmodium berghei: lack of antimalarial activity of an analogue of folate precursor, 2,4-diamino-6-hydroxymethylpteridine in a mouse model. Muregi FW; Kino H; Ishih A Exp Parasitol; 2008 Nov; 120(3):286-9. PubMed ID: 18789931 [TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase. Hekmat-Nejad M; Rathod PK Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087 [TBL] [Abstract][Full Text] [Related]
9. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways. Hardy LW; Matthews W; Nare B; Beverley SM Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081 [TBL] [Abstract][Full Text] [Related]
10. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae. Brophy VH; Vasquez J; Nelson RG; Forney JR; Rosowsky A; Sibley CH Antimicrob Agents Chemother; 2000 Apr; 44(4):1019-28. PubMed ID: 10722506 [TBL] [Abstract][Full Text] [Related]
11. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors. Nirmalan N; Sims PF; Hyde JE Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand. Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611 [TBL] [Abstract][Full Text] [Related]
13. Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp. Thielking DM; Destefano MS; Cynamon MH; Yeo AE Antimicrob Agents Chemother; 2003 Mar; 47(3):1174. PubMed ID: 12604567 [No Abstract] [Full Text] [Related]
15. New antifolate 4,4'-diaminodiphenyl sulfone substituted 2,4-diamino-5-benzylpyrimidines. Proof of their dual mode of action and autosynergism. Wiese M; Schmalz D; Seydel JK Arch Pharm (Weinheim); 1996 Mar; 329(3):161-8. PubMed ID: 9005816 [TBL] [Abstract][Full Text] [Related]
16. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists. Chello PL; McQueen CA; DeAngelis LM; Bertino JR Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151 [TBL] [Abstract][Full Text] [Related]
17. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations. Heinberg A; Kirkman L Ann N Y Acad Sci; 2015 Apr; 1342(1):10-8. PubMed ID: 25694157 [TBL] [Abstract][Full Text] [Related]
18. Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Nduati E; Diriye A; Ommeh S; Mwai L; Kiara S; Masseno V; Kokwaro G; Nzila A Parasitol Res; 2008 May; 102(6):1227-34. PubMed ID: 18259776 [TBL] [Abstract][Full Text] [Related]
19. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum. Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635 [TBL] [Abstract][Full Text] [Related]
20. Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro. Scott HV; Rieckmann KH; O'Sullivan WJ Trans R Soc Trop Med Hyg; 1987; 81(5):715-21. PubMed ID: 3329779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]